Stock Award Plans and Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense

The Company recognized stock-based compensation expense related to the issuance of stock option awards and restricted stock units to employees, non-employees and directors in the statements of operations as follows:

	Three Months Ended
	March 31,
	2025		2024
Cost of goods sold	$	41,718	$	23,387
Research and development		78,155		24,245
Selling, clinical, and marketing		80,239		46,121
General and administrative		340,092		226,535
Total	$	540,204	$	320,288